Descriptive study of the patient suffering from Acute Coronary Syndrom

  • Juan José Serra Bisbal Farmacia Comunitaria. Puente de Vadillos, Cuenca.
  • Joana Melero Lloret Servicio de Cardiología, Sección de Hemodinámica. Hospital General Universitario de Castellón. Universitat Jaume I.
  • Ana María Planas del Viejo Servicio de Cardiología, Sección de Hemodinámica. Hospital General Universitario de Castellón. Universitat Jaume I.
  • Alejandro Bellver Navarro Servicio de Cardiología, Sección de Hemodinámica. Hospital General Universitario de Castellón. Universitat Jaume I.
Keywords: Acute Coronary Syndrome, Cardiovascular Risk Factor, LDL-cholesterol

Abstract

Cardiovascular disease is the leading cause of death worldwide. It is estimated that in 2012 17.5 million people died because of it, which represents 31 % of all deaths in the world. 42 % of these deaths were attributed to ischemic heart disease. There are two main modalities in ischemic heart disease: a stable one in which the patient presents symptoms with a determined threshold of effort, and another acute one in which a rupture of the atheroma plaque forms a thrombus in the arterial lumen causing greater or lesser obstruction of the flow, with the consequent appearance of an Acute Coronary Syndrome (ACS). The objectives of the present retrospective observational study are to describe the cardiovascular risk factors, to define the use of the different antiplatelet drugs prescribed after hospital discharge and to analyze the general lipid control by subgroups (diabetes, dyslipidemia, age and sex) of a sample of patients who have suffered from ACS and have undergone a primary angioplasty.

Keywords: Acute Coronary Syndrome, LDL-cholesterol, Cardiovascular Risk Factor.

Published
2019-05-12